Zobrazeno 1 - 10
of 40
pro vyhledávání: '"Lucely Cetina-Pérez"'
Publikováno v:
Frontiers in Oncology, Vol 14 (2024)
Externí odkaz:
https://doaj.org/article/ce15bcaa646b41f6b9ff1663e648b1ed
Autor:
Tatiana Galicia-Carmona, Eder Alexandro Arango-Bravo, Jaime A. Coronel-Martínez, Lucely Cetina-Pérez, Elva G. Vanoye-Carlo, Ricardo Villalobos-Valencia, José A. García-Pacheco, Patricia Cortés-Esteban
Publikováno v:
Frontiers in Oncology, Vol 14 (2024)
Cervical cancer constitutes a significant health burden for women worldwide despite being preventable by vaccination and screening. Advanced stages of the disease are associated with a poor prognosis, and treatment approaches have seen little change
Externí odkaz:
https://doaj.org/article/315c97aa5bc64e9cb49a012581cd1baf
Autor:
Lucely Cetina-Pérez, Julissa Luvián-Morales, Merari Delgadillo-González, Denisse Castro-Eguiluz, Tatiana Galicia-Carmona, Kely Rely, Rita Vaca González, Gabriela Lugo-Martínez, Nadia García-Barrientos, Antonio Nateras
Publikováno v:
BMC Cancer, Vol 24, Iss 1, Pp 1-9 (2024)
Abstract Background In 2020, the highest incidence and mortality from cervical cancer (CC) were detected in low and middle-income countries. CC remains a health problem for women living in them. In Mexico, CC ranks second in cancer incidence and mort
Externí odkaz:
https://doaj.org/article/5a47083fc2834dc0b4a9f025ae4be4f0
Autor:
Eder Alexandro Arango-Bravo, Tatiana Galicia-Carmona, Lucely Cetina-Pérez, Celia Beatriz Flores-de la Torre, María Isabel Enríquez-Aceves, José Antonio García-Pacheco, Eva María Gómez-García
Publikováno v:
Frontiers in Oncology, Vol 14 (2024)
The objective of this review is to summarize the current scientific evidence to formulate clinical recommendations regarding the classification, diagnostic approach, and treatment of rare histological subtypes of cervical cancer; neuroendocrine carci
Externí odkaz:
https://doaj.org/article/1357eb42ba0d4a09b9440bf6d0adf879
Autor:
Lucely Cetina-Pérez, Julissa Luvián-Morales, Denisse Castro-Eguiluz, Tatiana Galicia-Carmona, Silvia E. Alarcón-Barrios, Eder A. Arango-Bravo, Samuel Rivera-Rivera, Gregorio Quintero-Beuló, Dolores Gallardo-Rincón, Vicente Madrid-Marina
Publikováno v:
Gaceta Mexicana de Oncología, Vol 22, Iss 4 (2023)
Antecedentes: La información sobre los recursos disponibles para tratar cáncer cervicouterino (CaCu) en el sistema de salud mexicano es insuficiente. Objetivo: Describir los recursos disponibles para CC en instituciones públicas de México. Métod
Externí odkaz:
https://doaj.org/article/d5acbe11ce5a47738ee3f630d9f5a3c0
Autor:
Tatiana Galicia-Carmona, Eder Arango-Bravo, Juan a Serrano-Olvera, Celia Flores-de La Torre, Ivan Cruz-Esquivel, Ricardo Villalobos-Valencia, Andrés Morán-Mendoza, Denisse Castro-Eguiluz, Lucely Cetina-Pérez
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 17, Iss 8, Pp 2617-2625 (2021)
Human papillomavirus (HPV) infection is a well-known cause of cervical cancer. Therapeutic cancer vaccines are part of the current therapeutic options for HPV-associated cancers. Axalimogen filolisbac (ADXS11-001) is an immunotherapy based on live at
Externí odkaz:
https://doaj.org/article/3872b6f340e5468fa49351ddbfd1ad01
Autor:
Alejandra Rocío Pérez-Martín, Denisse Castro-Eguiluz, Lucely Cetina-Pérez, Yadira Velasco-Torres, Antonio Bahena-González, Edgar Montes-Servín, Ernesto González-Ibarra, Raquel Espinosa-Romero, Dolores Gallardo-Rincón
Publikováno v:
Biomolecules & Biomedicine, Vol 22, Iss 4 (2022)
Endometrial cancer is the second gynecological cancer with the highest global incidence. Among many associated risk factors, metabolic syndrome is an important and preventable one. It comprises a group of conditions that often occur together: central
Externí odkaz:
https://doaj.org/article/4935761d2e2e45df976230ebca3bb3f7
Autor:
Dolores Gallardo-Rincón, Edgar Montes-Servín, Gabriela Alamilla-García, Elizabeth Montes-Servín, Antonio Bahena-González, Lucely Cetina-Pérez, Flavia Morales Vásquez, Claudia Cano-Blanco, Jaime Coronel-Martínez, Ernesto González-Ibarra, Raquel Espinosa-Romero, Rosa María Alvarez-Gómez, Abraham Pedroza-Torres, Denisse Castro-Eguiluz
Publikováno v:
Frontiers in Genetics, Vol 13 (2022)
Background: Ovarian cancer (OC) is gynecologic cancer with the highest mortality rate. It is estimated that 13–17% of ovarian cancers are due to heritable mutations in BRCA1 and BRCA2. The BRCA1 (BRCA1-Del ex9-12) Mexican founder mutation is respon
Externí odkaz:
https://doaj.org/article/8f8831a44578482bbad3fece7d1b1c49
Autor:
Dolores Gallardo-Rincón, Rosa María Álvarez-Gómez, Edgar Montes-Servín, Alfredo Toledo-Leyva, Elizabeth Montes-Servín, David Michel-Tello, Gabriela Alamilla-García, Antonio Bahena-González, Elizabeth Hernández-Nava, Veronica Fragoso-Ontiveros, Raquel Espinosa-Romero, Lucely Cetina-Pérez
Publikováno v:
Translational Oncology, Vol 13, Iss 2, Pp 212-220 (2020)
Ovarian cancer (OC) is an important cause of gynecologic cancer-related deaths. In Mexico, around 4700 new cases of OC are diagnosed per year and it represents the second cause of gynecological cancer mortality with more than 2700 deaths. Germline mu
Externí odkaz:
https://doaj.org/article/afac17eac85743b88e694f84a5e1c7e4
Autor:
Laura, Flores-Cisneros1,2, Lucely, Cetina-Pérez1, Tatiana, Galicia-Carmona1, Roberto, Jimenez-Lima1, Dulce, González-Islas3, Arturo, Parra-Solano1, Maricarmen, Gómez-Guzman1, Lilia, Castillo-Martínez4
Publikováno v:
Nutrition & Cancer. 2022, Vol. 74 Issue 7, p2444-2450. 7p. 2 Diagrams, 1 Chart.